Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreEisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreEisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read MoreThe Canadian government announced Monday it will no longer require people to wear masks on…
Read MoreThe Canadian government announced Monday it will no longer require people to wear masks on…
Read MorePfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MorePfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MoreThe first tallies for the new bivalent booster are out, with some 4.4 million people…
Read MoreThe first tallies for the new bivalent booster are out, with some 4.4 million people…
Read MoreA Food and Drug Administration official said this week that updated COVID-19 boosters for 5-…
Read More
‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist.
The Food and Drug Administration spent months probing the nationwide shortage in baby formula, and…
Read More